Share

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

Prevention and Early Detection Resources:

Early detection of breast and cervical cancer through screening can improve survival and reduce mortality by finding cancer at an early stage when treatment is more effective and less expensive. To save lives and reduce health care spending, the Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) is highly effective at detecting and treating breast and cervical cancer in people who may otherwise not be screened.

Early detection of cancer through screening can improve survival and reduce mortality by detecting cancer at an early stage when treatment is more effective. The most recent data show breast and lung cancer screening rates were lowest among American Indian and Alaska Native people compared to other race and ethnicities, and below all race and ethnicities combined for cervical, colorectal, and prostate cancer screening.

Tobacco use causes about one-third of cancer deaths in the nation overall, but the burden varies by state.

The Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) is highly effective at detecting and treating breast and cervical cancer in low-income, uninsured, and underinsured women – who may otherwise not be screened. The American Cancer Society Cancer Action Network (ACS CAN) urges Congress to reauthorize this critical program by passing the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act.

A critical factor for eliminating disparities and ensuring health equity is the guarantee that all people have access to quality, affordable health care.

For 30 years, the Centers for Disease Control and Prevention’s National Breast and Cervical Cancer Early Detection Program has decreased disparities in breast and cervical cancer deaths.

In 2024, an estimated 13,820 people in the U.S. will be diagnosed with invasive cervical cancer, and 4,360 will die from the disease. Cervical cancer can affect any person with a cervix and most often is caused by certain types of human papillomavirus (HPV). Persistent HPV infection causes almost all cervical cancers but fortunately there is a safe and effective vaccine against HPV.

Breast cancer is the most commonly diagnosed cancer and the second-leading cause of cancer death in women. Although incidence rates have increased slightly over the past decade, death rates from breast cancer have been consistently declining over the last three decades, largely due to increased screening rates and improved treatment.

ACS CAN calls on the administration to finalize FDA’s rules to prohibit the sale of menthol cigarettes and flavored cigars immediately. There is no scientific rationale for permitting any flavored tobacco product to remain on the market. To end cancer as we know it for everyone, tobacco use must be addressed and cannot be done without prohibiting the sale of menthol flavors and all flavored cigars.

Tobacco Control Resources:

Cigars, cigarillos, and little cigars pose a real danger to the long-term health of all Americans – especially young people – yet government regulation of these products lags behind that of cigarettes and e-cigarettes.

The American Cancer Society Cancer Action Network (ACS CAN) supports a comprehensive approach to tobacco control that includes significantly increasing excise taxes on all forms of tobacco. Regular, significant excise tax increases of $1.00 or more per pack of cigarettes are one of the most effective ways to prevent kids from starting to use cigarettes and to help adults quit. Tobacco excise taxes can also reduce tobacco-related health disparities among people with limited incomes, pregnant persons and among racial and ethnic populations.

 

In 1999, the U.S. Department of Justice (DOJ) filed a lawsuit against major tobacco manufacturers Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and Altria to hold the industry accountable for more than 50 years of conspiring to defraud the public in violation of the Racketeer Influenced and Corrupt Organizations (RICO) Act. Big Tobacco, an industry which has for decades knowingly addicted and endangered the lives of millions of Americans for their own profit, must now post the truth about their deadly products, including at the point-of-sale (POS) for approximately 220,000 tobacco retailers.

The U.S. Surgeon General declared youth e-cigarette use to be an epidemic. E-cigarettes are the most used tobacco product among youth and, like any tobacco product, are unsafe. E-cigarette use is also most common among younger adults. Action is urgently needed to reverse these dangerous trends.

Sustained, dedicated federal investment in tobacco control through the Centers for Disease Control and Prevention’s Office of Smoking and Health (OSH) is necessary to prevent initiation of tobacco products, monitor tobacco product use, identify tobacco related disparities, and promote effective strategies to help individuals who use tobacco products to successfully quit.

Tobacco excise taxes benefit people with limited incomes and reduce tobacco-related health disparities, especially when tobacco excise tax revenues are dedicated to cessation programs that serve people with limited incomes.

Implementation of graphic warnings in the U.S. has been thwarted by tobacco industry legal challenges. The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN), along with our partners, have fought back in the judicial system, using litigation to both compel the U.S. Food and Drug Administration (FDA) to issue graphic warning regulations and help the U.S. Department of Justice (DOJ) defend the regulations finalized by FDA.

Tobacco use is one of the primary causes of cancer-related health disparities - disproportionately impacting people by race, ethnicity, sexual orientation, gender identity, disability status, mental health, income and education levels, and geographic location. Eliminating health disparities depends heavily on eliminating tobacco use. ACS CAN is pursuing evidence-based policies at the local, state, and federal levels that aim to reduce disparities and improve health outcomes for all individuals.

Significant tobacco tax increases are one of the most effective ways to prevent kids from starting to use tobacco and help adults quit. Substantial increases in cigarette tax rates also generate new revenue. In fact, every state that has significantly increased its cigarette tax has also boosted its state revenue - even after accounting for revenue loss due to beneficial declines in cigarette purchases resulting from the tax increase. 

Screening Resources:

ACS CAN supports the Women and Lung Cancer Research and Preventive Services Act of 2023 by to accelerate progress in reducing mortality from lung cancer, including among women.

Our ability to continue to make progress against cancer relies heavily on eliminating inequities that exist in breast cancer prevention and treatment. That is why ACS CAN advocates for policies to reduce the disparities in breast cancer by improving access to prevention and early detection services, patient navigation services, insurance coverage, in-network facilities, and clinical trials.

The Centers for Disease Control and Prevention’s (CDC) Colorectal Cancer Control Program (CRCCP) provides grant funding to 20 state health departments, eight universities, two tribal organizations, and five other organizations to help prevent colorectal cancer, the third most common cancer in men and women and the second leading cause of cancer death in the U.S. for men and women combined.

Our latest survey finds that cancer patients and survivors would be less likely to stay current with preventive care, including recommended cancer screenings, if the provision requiring these services be covered at no cost were repealed. This survey also explores the challenges of limited provider networks and the need for patient navigation.

Prostate cancer is the most common cancer in Black men. Black men are over twice as likely to die from prostate cancer compared to every other racial and ethnic group and they are also more likely to be diagnosed at an advanced stage. Black men with lower-grade (less aggressive) disease are actually more likely to die from prostate cancer than white men. The reasons for this are complex and include interactions between social, behavioral and biological factors.

 

Colorectal cancer is the third most common cancer in men and women and the second leading cause of cancer death in men and women combined in the United States. Yet, about 1 in 3 adults aged 50 to 75 are not getting tested as recommended. This factsheet discusses the importance of screening for colorectal cancer and what can be done to improve screening in the U.S.

 

In the U.S., colorectal cancer is the third leading cause of cancer-related deaths in men and in women, and the second most common cause of cancer deaths when men and women are combined. Despite advancements in screening and treatment, CRC does not affect every community the same. 

If detected early, cervical cancer is one of the most successfully treatable cancers. Incidence and mortality rates of cervical cancer have declined by over 50 percent in the past 40 years, largely due to improved screening and early detection. However, the rate of decline has slowed in recent years. Efforts to reduce barriers to screening could greatly improve cervical cancer screening rates, particularly for disparate populations.

  •  

Healthy Eating and Active Living Resources:

ACS and ACS CAN submitted comments and recommendations regarding the White House Conference on Hunger, Nutrition, and Health, planned to be held in September 2022. 

ACS and ACS CAN submitted comments on Topics and Scientific Questions for the 2025-2030 Dietary Guidelines for Americans. 

  •